April 18, 2016 – The U.S. Department of Health and Human Services and Centers for Disease Control and Prevention recently released the Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV. What is new to this update? This update incorporates additional evidence regarding use of nonoccupational postexposure prophlasix (nPEP) from animal studies, human observational studies, and consideration of new antiretroviral medications that were approved since the 2005 guidelines, some of which have improved tolerability.
Other updates include:
- Use of rapid antigen/antibody (Ag/Ab) combination HIV test
- Schedule of laboratory evaluations of source and exposed persons
- Antimicrobial regimens for prophylaxis of sexually transmitted infections and hepatitis
- Suggested procedure for transitioning patient between PEP and HIV preexposure prophylaxis (PrEP), as appropriate